Cambridge, Mass. August 12, 2020 – Apnimed, a clinical-stage pharmaceutical company focused on advancing medicines to treat sleep apnea and related disorders, today announced that the company will present at Oppenheimer’s Private Life Sciences Company Call Series,...
CAMBRIDGE, Mass. Apnimed, a clinical-stage company focused on advancing pharmacologic treatments for sleep apnea and related disorders, today announced that Luigi Taranto Montemurro, M.D., a co-founder of the company, has joined the team full-time as Medical Director....
